Author: Webmaster

Join Our Calprotectin Community!

We are pleased to announce the launch of the new Calprotectin Community Support Forum! We hope the forum topics will provide you with helpful information during the current situation, and allow you to share and discuss your tips and experiences with fellow members of the Calprotectin Community. During these unprecedented times communication and support is

Continue Reading

Faecal Calprotectin Indicates Intestinal Inflammation in COVID-19

In this pilot study, a relation between GI symptoms, intestinal inflammation (determined by FC) and faecal SARS-CoV-2-RNA in hospitalised patients with COVID-19 who did not require intensive care measures was explored. Click here to visit the BMJ website to find out more about the study and its results.

Continue Reading
IBD Monitoring

Calprotectin is Now Part of the New ECCO & ESGAR Guidelines

Faecal calprotectin (FC) is now part of the new official European Crohn’s and Colitis Organisation (ECCO) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) guidelines.

Continue Reading

The New Faecal Calprotectin Care Pathway | NICE

The New Faecal Calprotectin Care Pathway, developed by Dr James Turvill, Consultant Gastroenterologist at York Teaching Hospitals NHS Foundation Trust, and implemented by the Yorkshire and Humber AHSN, supports the implementation of NICE guidance DG11, for the detection of inflammation in the bowel (i.e. IBS vs IBD). The innovative and sensitive pathway based will help

Continue Reading

Three Simple Tests Could Save the NHS at least £6.9 Billion

A report from BIVDA and Innovate UK has identified that wider use of some IVD tests could save money and improve patient care. As we celebrate the 70th anniversary of the NHS is this one way to strengthen its future? Calprotectin is one of the tests identified in the report. It is already utilised in the NHS,

Continue Reading
Calprotectin Goes Mobile

Big Changes Coming Soon to a Clinic Near You

Calprotectin Testing Goes Mobile With advances in technology and the ubiquitous use of mobile devices, a huge opportunity has arisen to change the way some healthcare services are provided. This is especially applicable to the management of chronic conditions. With most people owning a mobile device or tablet this becomes a convenient way for patients to

Continue Reading

NICE releases Medtech Innovation Briefing on calprotectin point of care and home testing for monitoring IBD treatment.

On 4th December 2017 the National Institute for Health and Care Excellence issued a Medtech Innovation Briefing [MIB132]: ‘Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease’. This describes the innovative aspect that test results can be acted on more quickly than waiting for standard laboratory tests and could help reduce colonoscopies and clinical appointments. Costs may

Continue Reading

Launch of IBD Toolkit for GPs

The RCGP, in partnership with Crohn’s and Colitis UK, has launched an IBD toolkit for GPs and healthcare professionals. Clinical Champion for Inflammatory Bowel Disease, Dr Kevin Barrett,  developed the toolkit with the patient representative Rachel Fowler and the project’s steering group. He comments “Inflammatory Bowel Disease affects at least 1 in 250 of the

Continue Reading
Evaluating CE Marked Protocols for fCAL turbo

Expanded Range of Instruments with CE Marked Protocols for BÜHLMANN fCAL® turbo assay

BÜHLMANN application specialist Christina Gabris has recently visited the UK to validate some new instrument protocols for the fCAL turbo assay. Christina spent time in hospitals around Newcastle to optimise CE marked protocols for the Beckman AU5800 and AU680. The range of instruments with CE marked protocols for fCAL turbo has now been expanded to 28 including: Roche: cobas c501 & c502, cobas c701

Continue Reading
Assays to meet increasing faecal calprotectin tests

Meeting the Demands for Increasing Faecal Calprotectin Tests

Labs are receiving increasing faecal calprotectin tests requests since NICE published Diagnostic Guideline 11: ‘Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel’. This recommends faecal calprotectin as a first-line test for patients presenting with gastrointestinal (GI) symptoms indicative of IBS or IBD. Pam Bowe, team manager in the Department of Biochemistry at the Cumberland Infirmary, describes the evolution of her laboratory procedures to cope

Continue Reading